#
Mydfrin Ophthalmic Solution
  • Professionals
  • FDA PI

Mydfrin Ophthalmic Solution

Generic name:phenylephrine hydrochloride
Dosage form: ophthalmic solution
Drug classes:Mydriatics, Ophthalmic antihistamines and decongestants

Medically reviewed by Drugs.com. Last updated on Sep 21, 2021.

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

WARNINGS SECTION

PHYSICIANS SHOULD COMPLETELY FAMILIARIZE THEMSELVES WITH THE COMPLETE CONTENTS OF THIS LEAFLET BEFORE PRESCRIBING PHENYLEPHRINE HYDROCHLORIDE.

DESCRIPTION SECTION

MYDFRIN® phenylephrine hydrochloride ophthalmic solution 2.5% is a sterile topical ophthalmic solution. The active ingredient is represented by the chemical structure:

Established name: Phenylephrine Hydrochloride
Chemical name: Benzenemethanol, 3-hydroxy-α-[(methylamino)methyl]-,hydrochloride (R) -.

Each mL contains: Active: phenylephrine HCl 2.5%. Preservative: benzalkonium chloride 0.01%. Inactives: boric acid, sodium bisulfite, edetate disodium, sodium hydroxide and/or hydrochloric acid (to adjust pH), purified water.

CLINICAL PHARMACOLOGY SECTION

MYDFRIN® phenylephrine hydrochloride ophthalmic solution 2.5% is an alpha receptor sympathetic agonist used in local ocular disorders because of its vasoconstrictor and mydriatic action. It exhibits rapid and moderately prolonged action, and it produces little rebound vasodilation. Systemic side effects are uncommon.

INDICATIONS & USAGE SECTION

MYDFRIN® phenylephrine hydrochloride ophthalmic solution 2.5% is recommended as a vasoconstrictor, decongestant, and mydriatic in a variety of ophthalmic conditions and procedures. Some of its uses are for pupillary dilation in uveitis (to p..